Medtronic PLC (MDT)

131.31
+0.63(+0.48%)
After Hours
131.02
-0.29(-0.22%)
- Real-time Data
  • Volume:
    2,739,783
  • Bid/Ask:
    131.00/131.90
  • Day's Range:
    130.35 - 131.71

MDT Overview

Prev. Close
130.68
Day's Range
130.35-131.71
Revenue
30.12B
Open
130.54
52 wk Range
94.64-132.3
EPS
2.66
Volume
2,739,783
Market Cap
176.47B
Dividend (Yield)
2.52
(1.93%)
Average Vol. (3m)
4,239,855
P/E Ratio
49.12
Beta
0.82
1-Year Change
32.37%
Shares Outstanding
1,343,904,180
Next Earnings Date
Aug 24, 2021
What is your sentiment on Medtronic PLC?
or
Market is currently closed. Voting is open during market hours.

Medtronic PLC News

Medtronic PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryNeutralSellStrong BuyStrong BuyStrong Buy

Medtronic PLC Company Profile

Medtronic PLC Company Profile

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Read More
  • Great Company in it's fullest
    0
    • This dont move
      0
      • -22%? Seriously?
        0
        • you have to Buy
          0
          • I'm glad I got this one at $90
            0
            • MDT WILL COME BACK SO I'M BUYING IT AT 95
              0
              • strong buy.. will bounce back to 93.
                0
                • they have had 3 reports of all good news and they continue to fall. ********
                  0
                  • any reason why ?
                    0
                  • Yousef Abu Shaikh  usually sell off after the dividend declaration.. should bounce back in few days
                    0
                • Shorters should think about getting out. This stock trades within a range for the last 3 months and it's now at its low point. Might spike tomorrow or at the very least retrace significantly.
                  1
                  • Two South Koreans recover from coronavirus after plasma therapy
                    0
                    • Telsa working with Medtronic to make ventilators
                      0
                      • buy now ..this is the least it will go
                        1
                        • Should i buy this stock today
                          1
                          • Good stock to daytrade.
                            2
                            • Speakem engliss
                              1
                              • me no ingles man
                                0
                              • Jan Chojnackine lo ehey
                                0
                            • parque no muestra ningun tipo de movimiento desde el dia 18 de enero 2019
                              0
                              • Muestra
                                0
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.